| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000021435 |
| Receipt No. | R000024725 |
| Official scientific title of the study | Development of eye treatment method using amniotic membrane |
| Date of disclosure of the study information | 2016/03/11 |
| Last modified on | 2016/09/16 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Development of eye treatment method using amniotic membrane | |
| Title of the study (Brief title) | Treatment using amniotic membrane | |
| Region |
|
|
| Condition | ||
| Condition | Corneal scleral perforation, Infectious keratoconjunctivitis, Glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of development and effectiveness of the new technique the clinical effects are expected |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Amniotic menbrane is expected utility as instead of the corneal donor |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | It is scheduled to undergo a Caesarean section at Tohoku University Hospital,who was to give a consent to this study. | |||
| Key exclusion criteria | Minor
Adult who does not have sufficient judgment Unconscious adult person Adult's attention must be paid to the disease name |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Shunji Yokokura |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Ophthalmology and Visual Science |
| Address | 1-2 Seiryocho Aobaku Sendai Miyagi |
| TEL | 022-717-7294 |
| yokokura@oph.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Shunji Yokokura |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Ophthalmology and Visual Science |
| Address | 1-2 Seiryocho Aobaku Sendai Miyagi |
| TEL | 022-717-7294 |
| Homepage URL | |
| yokokura@oph.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Recruitment methods of the subject (on top of the hospitalization at our facility, is scheduled to undergo a Caesarean section, meet the selection criteria, cases of consent)
The amniotic membrane is not risk for a tissue that is normally discarded during the Caesarean section, there is no privacy problems such for performing the coupling impossible anonymization. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024725 |